AI-guided design and optimization of a novel KIM-1-targeted peptide for bFGF delivery in acute kidney injury repair
Regenerative Biomaterials · 22.01.2026 · 13
DOI: 10.1093/rb/rbag050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 09.03.2026. Verfasst von Kaiyan Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy, Histology and Embryology, School of Basic Medicine, Qingdao University, Qingdao 266071, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young and Middle-aged Medical High-end Talent Project of Chongqing, Natural Science Foundation of Shandong Province, Key Research and Development Plan of Shandong Province.
Abstract (Originalsprache)
Acute kidney injury (AKI) remains a major clinical challenge due to its high incidence and mortality rates. Growth factor therapy has emerged as a promising strategy in AKI treatment, but it is limited by low targeting efficiency. Kidney injury molecule (KIM-1) is up-regulated after AKI and serves as a potential target for growth factor delivery systems. In this study, de novo designed WEV peptide targeting KIM-1 was screened to systematically optimize the affinity and specificity using a structure-based computational ‘anchor extension’ strategy integrated with deep learning approaches. The WEV peptide was computationally predicted and experimentally validated to have superior specificity and binding affinity with KIM-1 in vitro and in vivo. Then, a KIM-1-targeted recombinant WEV-bFGF protein was constructed to direct bFGF specifically to the ischemic kidney, which highly expressed KIM-1.This targeted delivery of WEV-bFGF could protect ischemic kidney, decrease cell apoptosis and inflammatory response, alleviate fibrosis and improve renal function. This process was revealed to activate tissue regeneration-related genes, while inhibiting genes related to apoptosis and inflammation, as determined by transcriptome analysis. Therefore, this optimized WEV peptide held a potential for a KIM-1 targeted growth factor delivery system and provided a new therapeutic strategy for AKI treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Anatomy, Histology and Embryology, School of Basic Medicine, Qingdao University, Qingdao 266071, China.
- Department of Urology of Jiangbei Campus, The First Affiliated Hospital of Army Medical University (The 958th Hospital of Chinese People's Liberation Army), Chongqing 400020, China.
- Department of Medicine, Qingdao University, Qingdao, Shandong Province 266071, China.
ORCID-Profile: Runxue Zhou, Chunying Shi, Wei Chen
Förderung
- Young and Middle-aged Medical High-end Talent Project of Chongqing
- Natural Science Foundation of Shandong Province
- Key Research and Development Plan of Shandong Province
Zitieren
APA
Su, K., Liu, Z., Fu, P., Zhou, R., Xia, H., Nie, W., Sun, S., Shi, C., & Chen, W. (2026). AI-guided design and optimization of a novel KIM-1-targeted peptide for bFGF delivery in acute kidney injury repair. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag050
Vancouver
Su K, Liu Z, Fu P, Zhou R, Xia H, Nie W, et al. AI-guided design and optimization of a novel KIM-1-targeted peptide for bFGF delivery in acute kidney injury repair. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag050
BibTeX
@article{Su2026,
author = {Su, Kaiyan and Liu, Zhuo and Fu, Pengrui and Zhou, Runxue and Xia, Hao and Nie, Weihong and Sun, Shuwei and Shi, Chunying and Chen, Wei},
title = {AI-guided design and optimization of a novel KIM-1-targeted peptide for bFGF delivery in acute kidney injury repair},
journal = {Regenerative Biomaterials},
year = {2026},
volume = {13},
doi = {10.1093/rb/rbag050}
}
EUVIMED